Jie Min Lam

2.6k citations
14 papers · 135 indexed · h-index 6
Topics
Bladder and Urothelial Cancer Treatments (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)Renal cell carcinoma treatment (2 papers)

In The Last Decade

Jie Min Lam

14 papers receiving 127 citations

Peers

Jie Min Lam
Comparison fields: 5 of 73
  • Biomedical Engineering 31
  • Molecular Biology 24
  • Physiology 24
  • Cellular and Molecular Neuroscience 18
  • Biomaterials 18
Replace Junxiang Gu with:
Junxiang Gu China
Tsvetelina Baryakova United States
Tomomi Akita Japan
Insiya Mukadam United States
Daoying Geng China
Yuncin Luo United States
Ann‐Kathrin Rahm Germany
Jiarong Yan China
Jie Min Lam relative to Junxiang Gu China Junxiang Gu's profile →
Citations per field
00.5×
Junxiang Gu · 1×
Citations per year

Countries citing papers authored by Jie Min Lam

Since Specialization
Citations

This map shows the geographic impact of Jie Min Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Min Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Min Lam more than expected).

Fields of papers citing papers by Jie Min Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Min Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Min Lam. The network helps show where Jie Min Lam may publish in the future.

Co-authorship network of co-authors of Jie Min Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Min Lam. A scholar is included among the top collaborators of Jie Min Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Min Lam. Jie Min Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 2
3 7
4 1
5 4
6 1
7 9
8 60
9 4
10 5
11 5
12 16
13
P53 IS AN INDEPENDENT PREDICTOR OF TUMOR RECURRENCE AND PROGRESSION AFTER NEPHRECTOMY IN PATIENTS WITH LOCALIZED RCC
2
14 17

About Jie Min Lam

Jie Min Lam is a scholar working on Geriatrics and Gerontology, Health Information Management and Applied Psychology, having authored 14 papers that have together received 135 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Biomaterials (18 citations), Geriatrics and Gerontology (4 citations) and Cellular and Molecular Neuroscience (18 citations). Jie Min Lam has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Aaron Tan, Keyoumars Ashkan, Anil Kumar, Hong Liu, Justin Tang, Joanna Wong, Jin Xie, Lewis Thorne, G Natasha and James N. Bergman. Their work appears in journals such as Advanced Functional Materials, Sports Medicine and Canadian Medical Association Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026